Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matt Kalaycio

Showing results (81-90 of 155) with videos related to

Pageof 16
Sort By:
American Journal of Hematology|January 22, 2019
Progression with clinical features is associated with worse subsequent survival in multiple myelomaRajshekhar Chakraborty, Hien D Liu, Lisa Rybicki, et al.
Hematology/Oncology and Stem Cell Therapy|September 12, 2025
Myeloablative and Reduced Intensity Allogeneic Transplant in Patients with Myeloproliferative NeoplasmsAndrew D Trunk, Yanwen Chen, Aaron T Gerds, et al.
Hematology/Oncology and Stem Cell Therapy|July 18, 2015
Long-term survival after high-dose chemotherapy with autologous hematopoietic cell transplantation in metastatic breast cancerBetty Ky Hamilton, Lisa Rybicki, Donna Abounader, et al.
Transplantation and Cellular Therapy|January 25, 2022
Comparison of Quality of Life and Outcomes between Haploidentical and Matched Related/Unrelated Donor Allogeneic Hematopoietic Cell TransplantationSanghee Hong, Lisa Rybicki, Linda Mclellan, et al.
Blood|July 21, 2011
An antiapoptotic BCL-2 family expression index predicts the response of chronic lymphocytic leukemia to ABT-737Sayer Al-Harbi, Brian T Hill, Suparna Mazumder, et al.
Seminars in Oncology|February 1, 2012
p53-Independent, normal stem cell sparing epigenetic differentiation therapy for myeloid and other malignanciesYogen Saunthararajah, Pierre Triozzi, Brian Rini, et al.
Clinical Lymphoma, Myeloma & Leukemia|May 16, 2015
Non-t(6;9) and Non-Inv(3) Balanced Chromosomal Rearrangements Are Associated With Poor Survival Outcomes in Myelodysplastic SyndromesJing Ai, Valeria Visconte, Ali Tabarroki, et al.
Journal of Clinical Apheresis|November 15, 2017
Neutropenic fever during peripheral blood progenitor cell mobilization is associated with decreased CD34+ cell collection and increased apheresis collection daysJack Khouri, Lisa Rybicki, Navneet Majhail, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|July 28, 2014
Synergistic effect of major histocompatibility complex class I-related chain a and human leukocyte antigen-DPB1 mismatches in association with acute graft-versus-host disease after unrelated donor hematopoietic stem cell transplantationMedhat Askar, Yuchu Sun, Lisa Rybicki, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 8, 2006
Pentostatin, cyclophosphamide, and rituximab is an active, well-tolerated regimen for patients with previously treated chronic lymphocytic leukemiaNicole Lamanna, Matt Kalaycio, Peter Maslak, et al.
Pageof 16

Showing results (81-90 of 155) with videos related to

Sort By:
Pageof 16
American Journal of Hematology|January 22, 2019
Progression with clinical features is associated with worse subsequent survival in multiple myelomaRajshekhar Chakraborty, Hien D Liu, Lisa Rybicki, et al.
Hematology/Oncology and Stem Cell Therapy|September 12, 2025
Myeloablative and Reduced Intensity Allogeneic Transplant in Patients with Myeloproliferative NeoplasmsAndrew D Trunk, Yanwen Chen, Aaron T Gerds, et al.
Hematology/Oncology and Stem Cell Therapy|July 18, 2015
Long-term survival after high-dose chemotherapy with autologous hematopoietic cell transplantation in metastatic breast cancerBetty Ky Hamilton, Lisa Rybicki, Donna Abounader, et al.
Transplantation and Cellular Therapy|January 25, 2022
Comparison of Quality of Life and Outcomes between Haploidentical and Matched Related/Unrelated Donor Allogeneic Hematopoietic Cell TransplantationSanghee Hong, Lisa Rybicki, Linda Mclellan, et al.
Blood|July 21, 2011
An antiapoptotic BCL-2 family expression index predicts the response of chronic lymphocytic leukemia to ABT-737Sayer Al-Harbi, Brian T Hill, Suparna Mazumder, et al.
Seminars in Oncology|February 1, 2012
p53-Independent, normal stem cell sparing epigenetic differentiation therapy for myeloid and other malignanciesYogen Saunthararajah, Pierre Triozzi, Brian Rini, et al.
Clinical Lymphoma, Myeloma & Leukemia|May 16, 2015
Non-t(6;9) and Non-Inv(3) Balanced Chromosomal Rearrangements Are Associated With Poor Survival Outcomes in Myelodysplastic SyndromesJing Ai, Valeria Visconte, Ali Tabarroki, et al.
Journal of Clinical Apheresis|November 15, 2017
Neutropenic fever during peripheral blood progenitor cell mobilization is associated with decreased CD34+ cell collection and increased apheresis collection daysJack Khouri, Lisa Rybicki, Navneet Majhail, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|July 28, 2014
Synergistic effect of major histocompatibility complex class I-related chain a and human leukocyte antigen-DPB1 mismatches in association with acute graft-versus-host disease after unrelated donor hematopoietic stem cell transplantationMedhat Askar, Yuchu Sun, Lisa Rybicki, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 8, 2006
Pentostatin, cyclophosphamide, and rituximab is an active, well-tolerated regimen for patients with previously treated chronic lymphocytic leukemiaNicole Lamanna, Matt Kalaycio, Peter Maslak, et al.
Pageof 16